Ero1-Lα plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer
The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Oxygen is the ultimate source of oxidizing power for disulfide bond formation, suggesting that under limiting oxygen proper protein folding might be compromised. We show that secretion of vascular endothelial growth factor (VEGF), a protein with multiple disulfide bonds, was indeed impeded under hypoxia and was partially restored by artificial increase of oxidizing equivalents with diamide. Physiologically, the oxireductase endoplasmic reticulum oxidoreductin-1 (Ero1)-L alpha, but not other proteins in the relay of disulfide formation, was strongly upregulated by hypoxia and independently by hypoglycemia, two known accompaniments of tumors. Further, we provide genetic evidence that induction of Ero1-L alpha by hypoxia and hypoglycemia is mediated by the transcription factor hypoxia-inducible factor 1 (HIF-1) but is independent of p53. In natural human tumors, Ero1-L alpha mRNA was specifically induced in hypoxic microenvironments coinciding with that of upregulated VEGF expression. To establish a physiological relevance to modulations in Ero1-L alpha levels, we showed that even a modest, two- to three-fold reduction in Ero1-L alpha production via siRNA leads to significant inhibition of VEGF secretion, a compromised proliferation capacity and enhanced apoptosis. Together, these findings demonstrate that hypoxic induction of Ero1-L alpha is the key adaptive response in a previously unrecognized HIF-1-mediated pathway that operates to improve protein secretion under hypoxia and might be harnessed for inhibiting tumor growth via inhibiting VEGF-driven angiogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of hypoxia [175, 176], reduced nutrient availability [177, 178], accumulation of reactive oxygen species [179, 180] and a decreased pH within the TME [180, 181] contribute to a chronic upregulation of ER stress in the TME, impacting the fate and survival of cancer cells.”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [176]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 2×
“These cells were chosen in order to provide a sensitized background, and since HIF-1 activity is redox sensitive (Wang et al., 1995b).”
BackgroundJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“…expression is also induced by the iron chelator desferrioxamine (DFO), which is known to inhibit the prolyl-hydroxylase responsible for HIF-1 degradation (Ivan et al., 2001; Jaakkola et al., 2001) and, hence, frequently used as surrogate hypoxia marker in HIF-1-mediated responses (data not shown).”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“…expression is also induced by the iron chelator desferrioxamine (DFO), which is known to inhibit the prolyl-hydroxylase responsible for HIF-1 degradation (Ivan et al., 2001; Jaakkola et al., 2001) and, hence, frequently used as surrogate hypoxia marker in HIF-1-mediated responses (data not shown).”
BackgroundVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617 · cited 3×
“…keshet@cc.huji.ac.il Oncogene (2005) 24, 1011–1020 & 2005 Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc mRNA (Shweiki et al., 1992; Ikeda et al., 1995; Shima et al., 1995) and an internal ribosome entry site (IRES) refractory to hypoxia is used to secure…”
BackgroundMethodInfluentialSelf-citationActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 2×
“HIF-1 target genes play key roles in multiple pathways, including angiogenesis, vascular reactivity and remodeling, glucose and energy metabolism, cell proliferation and survival, erythropoiesis, iron homeostasis and others (Carmeliet et al., 1998) (for a review see Semenza, 2000).”
BackgroundMethodSelf-citationHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · cited 1×
“Since hypoxia is known to be a major selection force in p53-deficient (Graeber et al., 1996), ability to upregulate Ero1-La in hypoxic microenvironments of these tumors is physiologically relevant.”
BackgroundRegulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G. L., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,897
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Differentiated Rat Glial Cell Strain in Tissue Culture
Benda, P., Lightbody, J., Sato, G., Levine, L., & Sweet, W. (1968) · Science · doi:10.1126/science.161.3839.370 · Cited by 1,472
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468 · cited 2×
“Adaptive and corrective responses to hypoxia involving increased transcription are orchestrated by dedicated transcription factors, primarily by HIF-1 (Wang and Semenza, 1993; Semenza, 1999, 2000).”
BackgroundA trip to the ER: coping with stress
Rutkowski, D. T., & Kaufman, R. J. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.11.001 · Cited by 1,355
Oxidative protein folding in eukaryotes
Tu, B. P., & Weissman, J. S. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200311055 · Cited by 1,041
Stabilization of wild-type p53 by hypoxia-inducible factor 1α
An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. M. (1998) · Nature · doi:10.1038/32925 · Cited by 827
Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., & Simon, M. C. (1997) · Nature · doi:10.1038/386403a0 · Cited by 781 · cited 2×
“Several HIF-1 target genes are also regulated by hypoglycemia (Stein et al., 1995; Maltepe et al., 1997).”
BackgroundIkeda, E., Achen, M. G., Breier, G., & Risau, W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19761 · Cited by 594
Firth, J. D., Ebert, B. L., Pugh, C. W., & Ratcliffe, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6496 · Cited by 525
Stein, I., Itin, A., Einat, P., Skaliter, R., Grossman, Z., & Keshet, E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3112 · Cited by 498
Self-citationThe ERO1 Gene of Yeast Is Required for Oxidation of Protein Dithiols in the Endoplasmic Reticulum
Frand, A. R., & Kaiser, C. A. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80017-9 · Cited by 494
Stein, I., Neeman, M., Shweiki, D., Itin, A., & Keshet, E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5363 · Cited by 455
Self-citationMuller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., & de Vos, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7192 · Cited by 452
Biochemical Basis of Oxidative Protein Folding in the Endoplasmic Reticulum
Tu, B. P., Ho-Schleyer, S. C., Travers, K. J., & Weissman, J. S. (2000) · Science · doi:10.1126/science.290.5496.1571 · Cited by 447
Tu, B. P., & Weissman, J. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00696-2 · Cited by 433
Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis.
Motro, B., Itin, A., Sachs, L., & Keshet, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3092 · Cited by 346
Self-citationCrystallographic structure of the T domain–DNA complex of the Brachyury transcription factor
Müller, C. W., & Herrmann, B. G. (1997) · Nature · doi:10.1038/39929 · Cited by 324
Shima, D. T., Deutsch, U., & D'Amore, P. A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00831-s · Cited by 305
Pagani, M., Fabbri, M., Benedetti, C., Fassio, A., Pilati, S., Bulleid, N. J., Cabibbo, A., & Sitia, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003061200 · Cited by 269
Mazzarella, R. A., Srinivasan, M., Haugejorden, S. M., & Green, M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40163-4 · Cited by 254
Sciandra, J. J., Subjeck, J. R., & Hughes, C. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4843 · Cited by 225
Modeling dependencies in protein-DNA binding sites
Barash, Y., Elidan, G., Friedman, N., & Kaplan, T. (2003) · Proceedings of the seventh annual international conference on Research in computational molecular biology · doi:10.1145/640075.640079 · Cited by 202
Kuwabara, K., Matsumoto, M., Ikeda, J., Hori, O., Ogawa, S., Maeda, Y., Kitagawa, K., Imuta, N., Kinoshita, T., Stern, D. M., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5025 · Cited by 195
Calnexin, Calreticulin, and ERp57: Teammates in Glycoprotein Folding
Ellgaard, L., & Frickel, E.-M. (2003) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:39:3:223 · Cited by 180
Sullivan, D. C., Huminiecki, L., Moore, J. W., Boyle, J. J., Poulsom, R., Creamer, D., Barker, J., & Bicknell, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308124200 · Cited by 180
Sevier, C. S., Cuozzo, J. W., Vala, A., Åslund, F., & Kaiser, C. A. (2001) · Nature Cell Biology · doi:10.1038/ncb1001-874 · Cited by 178
Effect of Altered Redox States on Expression and DNA-Binding Activity of Hypoxia-Inducible Factor 1
Wang, G. L., Jiang, B. H., & Semenza, G. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2005 · Cited by 172
Endoh, H., Tomida, S., Yatabe, Y., Konishi, H., Osada, H., Tajima, K., Kuwano, H., Takahashi, T., & Mitsudomi, T. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.109 · Cited by 172
Hypoxia-Inducible Factor-1α Mediates Hypoxia-Induced Delayed Neuronal Death That Involves p53
Halterman, M. W., Miller, C. C., & Federoff, H. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06818.1999 · Cited by 159
The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1‐Lα
Gess, B., Hofbauer, K., Wenger, R. H., Lohaus, C., Meyer, H. E., & Kurtz, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03590.x · Cited by 132
Claffey, K. P., Senger, D. R., & Spiegelman, B. M. (1995) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(94)00144-6 · Cited by 102
Pötgens, A. J., Lubsen, N. H., van Altena, M. C., Vermeulen, R., Bakker, A., Schoenmakers, J. G., Ruiter, D. J., & de Waal, R. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)30073-9 · Cited by 101
Molecular aspects of oxygen sensing in physiological adaptation to hypoxia
Czyzyk-Krzeska, M. (1997) · Respiration Physiology · doi:10.1016/s0034-5687(97)00076-5 · Cited by 63
Cited by
Endoplasmic reticulum stress signals in the tumour and its microenvironment
Chen, X., & Cubillos-Ruiz, J. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00312-2 · Cited by 1,356
Moncada, R., Barkley, D., Wagner, F., Chiodin, M., Devlin, J. C., Baron, M., Hajdu, C. H., Simeone, D. M., & Yanai, I. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0392-8 · Cited by 1,045
Hypoxia signalling through mTOR and the unfolded protein response in cancer
Wouters, B. G., & Koritzinsky, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2501 · Cited by 894
Raturi, A., & Simmen, T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.04.013 · Cited by 447
“Hypoxic cancer tissue shows HIF1α-dependent upregulation of Ero1α, which leads to tumor cell proliferation [195].”
BackgroundIntegrated Endoplasmic Reticulum Stress Responses in Cancer
Moenner, M., Pluquet, O., Bouchecareilh, M., & Chevet, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1705 · Cited by 433
“This is the case for the protein disulfide isomerase (PDI)-like protein ERp29 and for the ER oxidase Ero1 in basal skin carcinomas and breast carcinomas, respectively (4, 5).”
Background
Metadata
- Authors
- May, D., Itin, A., Gal, O., Kalinski, H., Feinstein, E., & Keshet, E.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Corresponding author
- Keshet, Eli
- Venue
- Oncogene
- Published
- 2004-12-13
- Volume
- 24
- Issue
- 6
- Pages
- 1011-1020
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2030976357
- Cited by
- 167
- References
- 44
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 10 · 2023: 11 · 2022: 8 · 2021: 15 · 2020: 9 · 2019: 5 · 2018: 12 · 2017: 4 · 2016: 9 · 2015: 7 · 2014: 7 · 2013: 5 · 2012: 9
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- hypoxia, HIF-1, disulfide bond formation, VEGF secretion, protein folding, hypoglycemia, tumor hypoxia, angiogenesis, apoptosis, tumor growth, p53-independent regulation
- MeSH terms
- Animals, Brain Neoplasms, DNA-Binding Proteins, Glioma, Carcinoma, Hepatocellular, Humans, Hypoglycemia, Liver Neoplasms, Membrane Glycoproteins, Mice, Nude, Neovascularization, Pathologic, Nuclear Proteins, Oxidoreductases, Transcription Factors, Tumor Cells, Cultured, Cell Hypoxia, Up-Regulation, Apoptosis, Helix-Loop-Helix Motifs, Vascular Endothelial Growth Factor A, Cell Proliferation, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.